BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 27412291)

  • 21. Selective orexin 1 receptor antagonist SB-334867 aggravated cognitive dysfunction in 3xTg-AD mice.
    Gao WR; Hu XH; Yu KY; Cai HY; Wang ZJ; Wang L; Wu MN
    Behav Brain Res; 2023 Feb; 438():114171. PubMed ID: 36280008
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of Retinoid X Receptors (RXRs) and dietary vitamin A in Alzheimer's disease: Evidence from clinicopathological and preclinical studies.
    Biyong EF; Tremblay C; Leclerc M; Caron V; Alfos S; Helbling JC; Rodriguez L; Pernet V; Bennett DA; Pallet V; Calon F
    Neurobiol Dis; 2021 Dec; 161():105542. PubMed ID: 34737043
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The flavonoid baicalein rescues synaptic plasticity and memory deficits in a mouse model of Alzheimer's disease.
    Gu XH; Xu LJ; Liu ZQ; Wei B; Yang YJ; Xu GG; Yin XP; Wang W
    Behav Brain Res; 2016 Sep; 311():309-321. PubMed ID: 27233830
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human neural stem cells improve cognition and promote synaptic growth in two complementary transgenic models of Alzheimer's disease and neuronal loss.
    Ager RR; Davis JL; Agazaryan A; Benavente F; Poon WW; LaFerla FM; Blurton-Jones M
    Hippocampus; 2015 Jul; 25(7):813-26. PubMed ID: 25530343
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mammalian target of rapamycin: a valid therapeutic target through the autophagy pathway for Alzheimer's disease?
    Cai Z; Zhao B; Li K; Zhang L; Li C; Quazi SH; Tan Y
    J Neurosci Res; 2012 Jun; 90(6):1105-18. PubMed ID: 22344941
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PIM1 protein kinase regulates PRAS40 phosphorylation and mTOR activity in FDCP1 cells.
    Zhang F; Beharry ZM; Harris TE; Lilly MB; Smith CD; Mahajan S; Kraft AS
    Cancer Biol Ther; 2009 May; 8(9):846-53. PubMed ID: 19276681
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Soluble Aβ levels correlate with cognitive deficits in the 12-month-old APPswe/PS1dE9 mouse model of Alzheimer's disease.
    Zhang W; Hao J; Liu R; Zhang Z; Lei G; Su C; Miao J; Li Z
    Behav Brain Res; 2011 Sep; 222(2):342-50. PubMed ID: 21513747
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cognitive-Enhancing Effects of a Polyphenols-Rich Extract from Fruits without Changes in Neuropathology in an Animal Model of Alzheimer's Disease.
    Dal-Pan A; Dudonné S; Bourassa P; Bourdoulous M; Tremblay C; Desjardins Y; Calon F;
    J Alzheimers Dis; 2017; 55(1):115-135. PubMed ID: 27662290
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel GLP-1/GIP/Gcg triagonist reduces cognitive deficits and pathology in the 3xTg mouse model of Alzheimer's disease.
    Li T; Jiao JJ; Hölscher C; Wu MN; Zhang J; Tong JQ; Dong XF; Qu XS; Cao Y; Cai HY; Su Q; Qi JS
    Hippocampus; 2018 May; 28(5):358-372. PubMed ID: 29473979
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Propranolol reduces cognitive deficits, amyloid and tau pathology in Alzheimer's transgenic mice.
    Dobarro M; Gerenu G; Ramírez MJ
    Int J Neuropsychopharmacol; 2013 Nov; 16(10):2245-57. PubMed ID: 23768694
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mithramycin A Alleviates Cognitive Deficits and Reduces Neuropathology in a Transgenic Mouse Model of Alzheimer's Disease.
    Wei C; Zhang W; Zhou Q; Zhao C; Du Y; Yan Q; Li Z; Miao J
    Neurochem Res; 2016 Aug; 41(8):1924-38. PubMed ID: 27072684
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sirtuin 2 Inhibition Improves Cognitive Performance and Acts on Amyloid-β Protein Precursor Processing in Two Alzheimer's Disease Mouse Models.
    Biella G; Fusco F; Nardo E; Bernocchi O; Colombo A; Lichtenthaler SF; Forloni G; Albani D
    J Alzheimers Dis; 2016 Jun; 53(3):1193-207. PubMed ID: 27372638
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pyruvate prevents the development of age-dependent cognitive deficits in a mouse model of Alzheimer's disease without reducing amyloid and tau pathology.
    Isopi E; Granzotto A; Corona C; Bomba M; Ciavardelli D; Curcio M; Canzoniero LM; Navarra R; Lattanzio R; Piantelli M; Sensi SL
    Neurobiol Dis; 2015 Sep; 81():214-24. PubMed ID: 25434488
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacologic reversal of neurogenic and neuroplastic abnormalities and cognitive impairments without affecting Aβ and tau pathologies in 3xTg-AD mice.
    Blanchard J; Wanka L; Tung YC; Cárdenas-Aguayo Mdel C; LaFerla FM; Iqbal K; Grundke-Iqbal I
    Acta Neuropathol; 2010 Nov; 120(5):605-21. PubMed ID: 20697724
    [TBL] [Abstract][Full Text] [Related]  

  • 35. S14G-humanin improves cognitive deficits and reduces amyloid pathology in the middle-aged APPswe/PS1dE9 mice.
    Zhang W; Zhang W; Li Z; Hao J; Zhang Z; Liu L; Mao N; Miao J; Zhang L
    Pharmacol Biochem Behav; 2012 Jan; 100(3):361-9. PubMed ID: 21993310
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intermittent Hypoxic Conditioning Rescues Cognition and Mitochondrial Bioenergetic Profile in the Triple Transgenic Mouse Model of Alzheimer's Disease.
    Correia SC; Machado NJ; Alves MG; Oliveira PF; Moreira PI
    Int J Mol Sci; 2021 Jan; 22(1):. PubMed ID: 33466445
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of COX1-2/5-LOX blockade in Alzheimer transgenic 3xTg-AD mice.
    Bitto A; Giuliani D; Pallio G; Irrera N; Vandini E; Canalini F; Zaffe D; Ottani A; Minutoli L; Rinaldi M; Guarini S; Squadrito F; Altavilla D
    Inflamm Res; 2017 May; 66(5):389-398. PubMed ID: 28238167
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Age and sex differences in motivation and spatial working memory in 3xTg-AD mice in the Hebb-Williams maze.
    Fertan E; Wong AA; Vienneau NA; Brown RE
    Behav Brain Res; 2019 Sep; 370():111937. PubMed ID: 31121220
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular and functional signatures in a novel Alzheimer's disease mouse model assessed by quantitative proteomics.
    Kim DK; Park J; Han D; Yang J; Kim A; Woo J; Kim Y; Mook-Jung I
    Mol Neurodegener; 2018 Jan; 13(1):2. PubMed ID: 29338754
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuropep-1 ameliorates learning and memory deficits in an Alzheimer's disease mouse model, increases brain-derived neurotrophic factor expression in the brain, and causes reduction of amyloid beta plaques.
    Shin MK; Kim HG; Baek SH; Jung WR; Park DI; Park JS; Jo DG; Kim KL
    Neurobiol Aging; 2014 May; 35(5):990-1001. PubMed ID: 24268884
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.